Risk of HBV liver disease in isolated antiHbc patients receiving immuno-chemotherapy for non Hodgkin lymphoma.

Targhetta, C

Risk of HBV liver disease in isolated antiHbc patients receiving immuno-chemotherapy for non Hodgkin lymphoma. [electronic resource] - Haematologica Nov 2008 - e66 p. digital

Publication Type: Journal Article

1592-8721

10.3324/haematol.13750 doi


Antiviral Agents--therapeutic use
Hepatitis B--drug therapy
Hepatitis C--drug therapy
Humans
Immunotherapy
Lymphoma, Non-Hodgkin--drug therapy
Risk Factors